Literature DB >> 24707151

Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.

Tong-Hong Niu1, Man Jiang1, Yong-Ning Xin1, Xiang-Jun Jiang1, Zhong-Hua Lin1, Shi-Ying Xuan1.   

Abstract

AIM: To investigate the association between two polymorphisms of apolipoprotein C3 (APOC3) and risk of nonalcoholic fatty liver disease (NAFLD) in a Chinese Han population.
METHODS: Genotypes for rs2854116 and rs2854117 in APOC3 and the known rs738409 in patatin-like phospholipase domain-containing protein 3 (PNPLA3) in 390 patients with NAFLD and 409 control subjects were determined by sequencing and polymerase chain reaction analysis. Serum lipid profiles were determined using biochemical methods, and an index of insulin resistance (IR, HOMA-IR), serum APOC3 concentrations and total antioxidant status (TAS) were also assessed.
RESULTS: No significant differences in genotype and allele frequencies of rs2854116 and rs2854117 were found between the NAFLD population and the controls (P > 0.05). The OR for the association between -455C and -482T allele carriers and the risk of NAFLD were 1.06 (95%CI: 0.72-1.57, P > 0.05) and 1.00 (95%CI: 0.68-1.48, P > 0.05), respectively. The variant carriers did not have a significantly increased risk of NAFLD or elevated clinical and biochemical parameters such as APOC3 concentrations, IR (1.42 ± 0.43 vs 1.48 ± 0.52, P > 0.05), liver enzymes and TAS (13.94 ± 2.01 vs 14.38 ± 1.92, P > 0.05) compared with the controls. Moreover, the results were similar when testing was carried out independent of the genetic variation in PNPLA3.
CONCLUSION: The two polymorphisms of the APOC3 gene are not associated with a risk of NAFLD, or with lipid profiles, IR and oxidative stress in the Chinese Han population.

Entities:  

Keywords:  Apolipoprotein C3; Insulin resistance; Nonalcoholic fatty liver disease; Oxidative stress; Polymorphism; Single nucleotide

Mesh:

Substances:

Year:  2014        PMID: 24707151      PMCID: PMC3974535          DOI: 10.3748/wjg.v20.i13.3655

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

Review 1.  Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.

Authors:  Roger K Schindhelm; Michaela Diamant; Jacqueline M Dekker; Maarten E Tushuizen; Tom Teerlink; Robert J Heine
Journal:  Diabetes Metab Res Rev       Date:  2006 Nov-Dec       Impact factor: 4.876

2.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Amy Wang; Sara A Beddow; John G Geisler; Mario Kahn; Xian-man Zhang; Brett P Monia; Sanjay Bhanot; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

3.  A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Authors:  Toni I Pollin; Coleen M Damcott; Haiqing Shen; Sandra H Ott; John Shelton; Richard B Horenstein; Wendy Post; John C McLenithan; Lawrence F Bielak; Patricia A Peyser; Braxton D Mitchell; Michael Miller; Jeffrey R O'Connell; Alan R Shuldiner
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

Review 4.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

Review 5.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Prog Lipid Res       Date:  2008-09-09       Impact factor: 16.195

6.  Liver fat in the metabolic syndrome.

Authors:  Anna Kotronen; Jukka Westerbacka; Robert Bergholm; Kirsi H Pietiläinen; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

7.  Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.

Authors:  Dongyan Zhang; Zhen-Xiang Liu; Cheol Soo Choi; Liqun Tian; Richard Kibbey; Jianying Dong; Gary W Cline; Philip A Wood; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

8.  Prevalence of fatty liver disease and its risk factors in the population of South China.

Authors:  Yong-Jian Zhou; Yu-Yuan Li; Yu-Qiang Nie; Jin-Xiang Ma; Lun-Gen Lu; Sheng-Li Shi; Min-Hu Chen; Pin-Jin Hu
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

9.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.

Authors:  Giorgio Bedogni; Stefano Bellentani; Lucia Miglioli; Flora Masutti; Marilena Passalacqua; Anna Castiglione; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2006-11-02       Impact factor: 3.067

10.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

View more
  21 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.

Authors:  Rui-Nan Zhang; Rui-Dan Zheng; Yu-Qiang Mi; Da Zhou; Feng Shen; Guang-Yu Chen; Chan-Yan Zhu; Qin Pan; Jian-Gao Fan
Journal:  Dig Dis Sci       Date:  2016-04-08       Impact factor: 3.199

3.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

4.  APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Xiaoyun Cheng; Jun Yamauchi; Sojin Lee; Ting Zhang; Zhenwei Gong; Radhika Muzumdar; Shen Qu; H Henry Dong
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

5.  Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.

Authors:  Min-Rui Li; Sheng-Hong Zhang; Kang Chao; Xian-Hua Liao; Jia-Yan Yao; Min-Hu Chen; Bi-Hui Zhong
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease.

Authors:  Wen-Yue Liu; Mohammed Eslam; Kenneth I Zheng; Hong-Lei Ma; Rafael S Rios; Min-Zhi Lv; Gang Li; Liang-Jie Tang; Pei-Wu Zhu; Xiao-Dong Wang; Christopher D Byrne; Giovanni Targher; Jacob George; Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-02-22

Review 7.  Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis.

Authors:  Haiying Zhang; Lizhen Chen; Yongning Xin; Yuangui Lou; Yang Liu; Shiying Xuan
Journal:  Hepat Mon       Date:  2014-10-15       Impact factor: 0.660

8.  Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China.

Authors:  Yuexin Zhang; Wen Cai; Jiangmei Song; Lei Miao; Bei Zhang; Qin Xu; Lijuan Zhang; Hua Yao
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 9.  Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.

Authors:  Renfan Xu; Anyu Tao; Shasha Zhang; Youbin Deng; Guangzhi Chen
Journal:  Sci Rep       Date:  2015-03-20       Impact factor: 4.379

10.  Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Nader Salari; Niloufar Darvishi; Kamran Mansouri; Hooman Ghasemi; Melika Hosseinian-Far; Fateme Darvishi; Masoud Mohammadi
Journal:  BMC Endocr Disord       Date:  2021-06-19       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.